News
WHO PQT-IVD Webinar – New Applicants to IVD Prequalification, 26 June 2024
A webinar for IVD manufacturers was held on 26 June.
Two PQT Medicines workshops for manufacturers
The PQT Medicines 7th Annual Medicines Quality Workshop for Manufacturers will take place from 23 to 26 September 2024.
REGISTRATION OPEN: 2024 annual joint UNICEF-UNFPA-WHO meeting with manufacturers and suppliers
Dear Colleagues,
ePQS Freeze until July 17
As you might be aware, WHO has embarked on a project to streamline and improve the process of receiving submissions through the implementation of the ePQS (electronic Prequalification Syste
WHO PQT-IVD Webinar – Product Dossier Assessment
A webinar for IVD manufacturers was held on We
Performance evaluations for IVDs for monitoring of blood glucose in capillary blood and HbA1c PoC Assays
On 12 April 2024 WHO announced the expansion of prequalification of in vitro diagnostics to include diabetes.
Macleods’ artesunate 120 mg for injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Mylan’s molnupiravir prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Request for Proposals: Support to the WHO Immunization and Equipment Pre-qualification Team
The WHO Immunization and Equipment Pre-qualification Team is seeking to enter into a contractual agreement with a successful bidder to implement the following work packages:
S Kant’s sulfadoxine/pyrimethamine tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
22nd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
The Invitation to Manufacturers of Antituberculosis Medicines to su
Ipca’s pyrimethamine/sulfadoxine dispersible tabl prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl + amodiaquine dispersible tabl prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Macleods’ flucytosine tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s dispersible isoniazid tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First azithromycin prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO to begin development of parallel recommendation and regulatory pathways; shortening the time taken for people to access health products
Ensuring access to quality-assured, safe and effective therapies is a core part of WHO’s mission.
Technical Specifications Series for WHO PQ of computer aided diagnosis of TB - for public comment (deadline 30 April 2024)
WHO Prequalification is inviting you to review the draft working document on Technical Specifications Series for submission to WHO Prequalification – Medical Device Assessment Screenin
First NRT products prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
ViiV Healthcare’s abacavir/dolutegravir/lamivudine pediatric dispersible tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Renata’s ethinylestradiol/levonorgestrel tabl prequalified
WHO Prequalification Unit (PQT) added the below new p
Merck’s praziquantel prequalified
WHO Prequalification Unit (PQT) added the below new p
First miltefosine prequalified
WHO Prequalification Unit (PQT) added the below new p
First cefiderocol prequalified
WHO Prequalification Unit (PQT) added the below new p
Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aurobindo’s molnupiravir prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: